CorporateCRITICAL RISK

Takeda Pharmaceuticals, U.S.A. Inc.

Risk Signals

Top Risk Score

→Stable

Total Exposure

$27.3M

Aggregate Risk Score

80/100

CRITICAL RISK

2 Risk Signals — Timeline

May 15, 202680$13.7M

Takeda Agrees to Pay $13.6M to Resolve False Claims Allegations

Takeda Pharmaceuticals, U.S.A. Inc. has agreed to pay $13,670,921 to resolve allegations of false claims to Medicare by paying kickbacks to induce prescriptions of Trintellix. The settlement addresses violations related to improper payments to healthcare providers.

May 14, 202680$13.7M

Takeda Agrees to Pay $13.6M to Resolve False Claims Allegations

Takeda Pharmaceuticals, U.S.A. Inc. has agreed to pay $13,670,921 to resolve allegations of false claims to Medicare by paying kickbacks to physicians for prescriptions of Trintellix. The violations occurred from January 2014 to October 2020 in California.

Related Organizations

New York Business Owner

Corporate80

Delta Home Health Care LLC

Corporate80

FIFA

Corporate60

HealthSplash

Corporate100

Chris and Isis Terry and IM Mastery Academy

Corporate80

Track risk signals for Takeda Pharmaceuticals, U.S.A. Inc. and thousands of other entities.

Get Free Alerts →View Intelligence Map →

Disclaimer: This profile aggregates publicly available risk signal data for informational purposes only. It does not assert fraud, criminal conduct, or legal violations.